+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Toronto Psoriatic Arthritis Screening (ToPAS) questionnaire: a report from the GRAPPA 2009 annual meeting



Toronto Psoriatic Arthritis Screening (ToPAS) questionnaire: a report from the GRAPPA 2009 annual meeting



Journal of Rheumatology 38(3): 546-547



The Toronto Psoriatic Arthritis Screening questionnaire (ToPAS) was developed as a tool to screen for psoriatic arthritis (PsA) in patients with psoriasis as well as in the general population. Thus, it differs from PsA-specific screening tools and may be used to screen for PsA in epidemiologic and family investigations. In a presentation at the 2009 annual meeting of GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) in Stockholm, Sweden, the authors described the development, testing, and validation of the ToPAS tool. Results of a comparison of the ToPAS questionnaire with the Psoriatic Arthritis Screening and Evaluation (PASE) questionnaire were also presented. Modification and further validation of the ToPAS are under way.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056607901

Download citation: RISBibTeXText

PMID: 21362783

DOI: 10.3899/jrheum.101117


Related references

Psoriatic Arthritis Screening and Evaluation (PASE) questionnaire and the role of dermatologists: a report from the GRAPPA 2009 annual meeting. Journal of Rheumatology 38(3): 548-550, 2011

Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS). Annals of the Rheumatic Diseases 68(4): 497-501, 2009

Composite Measures in Psoriatic Arthritis: a report from the GRAPPA 2009 annual meeting. Journal of Rheumatology 38(3): 540-545, 2011

Current challenges in the genetics of psoriatic arthritis: a report from the GRAPPA 2009 annual meeting. Journal of Rheumatology 38(3): 564-566, 2011

Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting. Journal of Rheumatology 43(5): 965-969, 2016

Cardiovascular comorbidities in psoriasis and psoriatic arthritis: pathogenesis, consequences for patient management, and future research agenda: a report from the GRAPPA 2009 annual meeting. Journal of Rheumatology 38(3): 567-571, 2011

THU0428Validation of the Toronto Psoriatic Arthritis Screen II (Topas II) Questionnaire in a Turkish Population. Annals of the Rheumatic Diseases 74(Suppl 2): 354.1-354, 2015

Validation of the Toronto Psoriatic Arthritis Screen II (TOPAS II) questionnaire in a Turkish population. Rheumatology International 38(2): 255-259, 2018

Distinguishing inflammatory from noninflammatory arthritis, enthesitis, and dactylitis in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. Journal of Rheumatology 39(2): 415-417, 2012

Genetics of psoriasis and psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. Journal of Rheumatology 39(2): 431-433, 2012

Update on biomarkers in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. Journal of Rheumatology 39(2): 427-430, 2012

Bone formation in psoriatic arthritis: a report from the GRAPPA 2013 Annual Meeting. Journal of Rheumatology 41(6): 1218-1219, 2015

Benchmarking Care in Psoriatic Arthritis - The QUANTUM Report: A Report from the GRAPPA 2016 Annual Meeting. Journal of Rheumatology 44(5): 674-678, 2017

Biomarkers of radiographic progression in psoriatic arthritis: a report from the GRAPPA 2011 annual meeting. Journal of Rheumatology 39(11): 2189-2192, 2013

Psoriatic arthritis and psoriasis projects in Italy: a report from the GRAPPA 2011 annual meeting. Journal of Rheumatology 39(11): 2201-2203, 2013